Express Scripts Holding Co (ESRX)

ESRX (NASDAQ:Health Services) EQUITY
$67.34
pos +0.00
+0.00%
Today's Range: 66.70 - 67.62 | ESRX Avg Daily Volume: 5,283,900
Last Update: 02/12/16 - 4:00 PM EST
Volume: 0
YTD Performance: -22.98%
Open: $0.00
Previous Close: $66.37
52 Week Range: $65.55 - $94.61
Oustanding Shares: 676,276,000
Market Cap: 44,884,438,120
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 9 9
Moderate Buy 0 1 1 1
Hold 10 9 9 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.11 2.03 1.97 1.97
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 20.68
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
20.68 20.50 26.86
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-20.29% -20.31% 23.89%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.10 1.19 0.29
Net Income 8.70 0.60 0.17
EPS 17.90 0.05 0.02
Earnings for ESRX:
EBITDA 5.85B
Revenue 100.89B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $1.55 $1.27 $5.53 $6.13
Number of Analysts 14 11 15 15
High Estimate $1.57 $1.36 $5.55 $6.26
Low Estimate $1.53 $1.22 $5.51 $5.60
Prior Year $1.39 $1.10 $4.88 $5.53
Growth Rate (Year over Year) 11.82% 15.54% 13.37% 10.80%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Don't be surprised if Anthem's threat to take its business elsewhere results in a compromise.
Bearish
Jan 19, 2016 | 7:46 AM EST
ESRX was downgraded to Market Perform, Leerink Partners said. $80 price target. Company is losing market share to CVS.
A weekly close below $80 will complete a top formation and likely precipitate further declines.
Don't catch falling knives, and don't ignore dividends.
A beginning-of-December look back at our portfolio through the lens of capital preservation.
A surge over $142 would generate more price gains.

Thank God It's Friday! Real Money Pro($)

Good morning! Bret Jensen here.
And four other things you need to know now.
ABBV gets FDA warning on Viekira Pak drug, GILD reaps the reward.

Columnist Conversations

I respectfully disagree. Scalia's passing will likely have little impact on the electorate or on a partisan Wa...
All; I've received a few questions about the subject of my column for this weekend about the implications of a...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.